CFM
NAUT icon

Catalyst Funds Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Catalyst Funds Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.3K Sell
26,340
-19,988
-43% -$52.8K ﹤0.01% 635
2026
Q1 		$180K Buy
+46,328
New +$114K 0.03% 465

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Catalyst Funds Management's NAUT Position: Q2 2026 in Review

Catalyst Funds Management reduced its Nautilus Biotechnolgy (NAUT) stake by 43% in Q2 2026, selling an estimated $52.8K and leaving 26,340 shares worth $49.3K. The position accounts for ﹤0.01% of the portfolio, ranked #635.

Catalyst Funds Management first reported a position in NAUT in Q1 2026 and has held it in 2 quarters since. The position peaked at $180K in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Catalyst Funds Management held 26,340 shares of Nautilus Biotechnolgy worth $49.3K as of Q2 2026.
  • Catalyst Funds Management sold 19,988 Nautilus Biotechnolgy shares in Q2 2026, an estimated $52.8K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Catalyst Funds Management's portfolio in Q2 2026, its #635 holding.
  • Catalyst Funds Management first reported a position in Nautilus Biotechnolgy in Q1 2026 and has held it in 2 quarters since.
  • Catalyst Funds Management's Nautilus Biotechnolgy position peaked at $180K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.